IGF-1 is positively associated with BMI in patients with acromegaly.

Anamil KhiyamiNeha MehrotraSharini VenugopalHussain MahmudGeorgios A ZenonosPaul A GardnerPouneh K Fazeli

Published in: Pituitary (2023)

In contrast to individuals without acromegaly, BMI is significantly and positively associated with IGF-1 in acromegaly across the weight spectrum. Future studies are needed to determine if obese patients with acromegaly experience more significant symptoms related to their disease, or if patients with a low BMI may require different diagnostic criteria.

Keyphrases

growth hormone
body mass index
weight gain
weight loss
adipose tissue
type diabetes
magnetic resonance
metabolic syndrome
physical activity
binding protein
current status
depressive symptoms
drug induced